The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
|Articles|May 3, 2021
Vaccine Manufacturer Warns Shortage in India Could Potentially Last Months
Author(s)Killian Meara
Aid shipments begin to arrive in India from the United States and Britain in efforts to help the country.
Advertisement
In India, amidst a devastating second wave of the COVID-19 pandemic, Adar Poonawalla, chief executive of India’s Serum Institute, stated on Sunday during an interview that a vaccine shortage in the country may last for months. Poonawalla claims the shortage is because the Indian government did not properly plan for the second wave of infections. A group of scientific advisors warned the government in early March of a potential second wave due to a more transmissible variant that was spreading, but authorities did not take the necessary precautions.
In Australia, the government expanded vaccine eligibility on Monday to those aged 50 years and older. The inoculation efforts were slowed due to concerns about a risk of blood clots with the AstraZeneca shot, which the country was mostly relying on. Prime Minister Scott Morrison has previously stated that he wants 4 million people vaccinated by the end of March, but officials have now clarified that he meant 4 million doses administered.
In Nepal, officials have halted all domestic and international flights over worries about a growing wave of COVID-19. Infections have been rapidly growing, with a 7 day average of more than 4,500 cases. On Sunday, the country reported 7,211 cases, and health experts have blamed the wave on migrant workers flowing from India.
China
275.34 million
19.13 per 100
United States
245.59 million
73.43 per 100
India
154.21 million
11.17 per 100
United Kingdom
49.83 million
73.41 per 100
Brazil
43.17 million
20.31 per 100
Germany
30.15 million
35.98 per 100
Turkey
23.01 million
27.28 per 100
France
22.28 million
32.7 per 100
Indonesia
20.17 million
7.38 per 100
Russia
20.07 million
13.75 per 100
Data Table per Our World in Data (May 2, 2021, 12 AM EST)
In the United States, nearly a third of Americans have been fully vaccinated, as cases continue to fall. On Sunday, the US reported 29,000 new COVID-19 cases, the lowest since early September.
California
31,185,031
78.92 per 100
Texas
19,205,116
66.23 per 100
New York
15,980,527
82.14 per 100
Florida
15,491,654
72.19 per 100
Pennsylvania
10,297,139
80.43 per 100
Illinois
9,642,236
76.09 per 100
Ohio
8,530,342
72.97 per 100
New Jersey
7,430,120
83.65 per 100
Michigan
7,281,555
72.91 per 100
North Carolina
7,168,548
68.34 per 100
Data Table per CDC COVID-19 Tracker (May 2, 2021, 6 AM EST)
For more information on COVID-19 vaccination research, distribution, and assessment, check out some of these recent Contagion stories:
Advertisement
Related to this article
An APP-driven complex outpatient antimicrobial therapy (COpAT) program for patients with bone and joint infections cut mean time to post-discharge follow-up from 20.1 to 9.7 days but did not significantly reduce 30-day readmissions or emergency department visits.
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
IDSA and ESCMID released 7 consensus statements to assist in managing individuals with Staphylococcus aureus Bacteremia (SAB). This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline.
Labcorp data presented at IDWeek 2026 show measles PCR testing nearly quadrupled and positivity rose sharply from April 2025 through March 2026, as clinicians shift toward guideline-recommended molecular testing amid ongoing US outbreaks.
Company announces first AI-designed personalized phage treatment for antibiotic-resistant bacterial infection in human patient.
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.
In this first IDWeek 2026 roundup, oral olorofim matched AmBisome in invasive aspergillosis, aztreonam-avibactam held activity as MBL-producing CRE rose, pritelivir cut hospitalizations in refractory HSV, and zelicapavir shortened RSV symptoms in high-risk adults.
Advertisement
Advertisement
Trending on Contagion Live
1
A Closer Look at IDSA/ESCMID 2026 Consensus Statements 6 and 7 on Staphylococcus aureus Bacteremia
2
Measles Update: October 30, 2026
3
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
4
Thinking Outside the IV: Implementation of a COpAT Program for Patients With Bone and Joint Infections
5